menu
    • menu

    Company profile for Cellectar

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer. Our core objective is to leverage our proprietary phospholipid drug conjugates™ (PDCs™) delivery platform to develop PDCs that specifically target cancer cells to deliver improved efficacy and better safety as a result of fewer off-target effects. The PDC™ platform possesses ...
    We are a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer. Our core objective is to leverage our proprietary phospholipid drug conjugates™ (PDCs™) delivery platform to develop PDCs that specifically target cancer cells to deliver improved efficacy and better safety as a result of fewer off-target effects. The PDC™ platform possesses the potential for the discovery and development of the next generation of cancer-targeting treatments and we plan to develop PDCs independently and through research and development collaborations.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CellectarUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Campus Drive, Suite 207 Florham Park, NJ 07932
    Telephone
    Telephone
    608-441-8120
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cellectar.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cellectar Bio Unveils Q3 2025 Financials And Corporate Update
    Cellectar Bio Unveils Q3 2025 Financials And Corporate Update

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187186/29076/en/Cellectar-Biosciences-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Cellectar Biosciences Reports Q3 Results, Hosts Earnings Call
    Cellectar Biosciences Reports Q3 Results, Hosts Earnings Call

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3182556/29076/en/Cellectar-Biosciences-to-Report-Third-Quarter-Financial-Results-and-Host-a-Conference-Call-on-Thursday-November-13-2025.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Cellectar Get FDA Rare Pediatric Tag for Iopofosine in HGG Glioma
    Cellectar Get FDA Rare Pediatric Tag for Iopofosine in HGG Glioma

    27 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/27/3174592/29076/en/Cellectar-Biosciences-Receives-Rare-Pediatric-Disease-Designation-from-U-S-Food-and-Drug-Administration-for-Iopofosine-I-131-in-Relapsed-or-Refractory-Pediatric-High-Grade-Glioma.html

    GLOBENEWSWIRE
    27 Oct 2025
    Share Share
    Cellectar Biosciences Unveils Encouraging Preclinical Data
    Cellectar Biosciences Unveils Encouraging Preclinical Data

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166189/29076/en/Cellectar-Biosciences-Presented-Promising-Preclinical-Data-in-Poster-Presentation-at-the-American-Association-for-Cancer-Research-AACR-Special-Conference-on-Pancreatic-Cancer-Resea.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    Cellectar Bio Raises $5.8M Through Agreements
    Cellectar Bio Raises $5.8M Through Agreements

    07 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/07/3162498/29076/en/Cellectar-Biosciences-Inc-Enters-Into-Agreements-to-Raise-5-8-Million.html

    GLOBENEWSWIRE
    07 Oct 2025
    Share Share
    EMA Confirms CMA For Cellectar’s Iopofosine In Macroglobulinemia
    EMA Confirms CMA For Cellectar’s Iopofosine In Macroglobulinemia

    06 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/06/3161577/29076/en/Cellectar-Biosciences-Announces-European-Medicines-Agency-EMA-Confirms-Eligibility-to-File-for-Conditional-Marketing-Authorization-CMA-for-Iopofosine-I-131-as-a-Treatment-for-Refra.html

    GLOBENEWSWIRE
    06 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search